| Multiple Sclerosis |
1 |
1 |
| Myelin |
0 |
0.58 |
| California |
0 |
0.39 |
| Demyelination |
0 |
0.39 |
| Healthcare and Medical Technology |
0 |
0.27 |
| Optic Neuropathy |
0 |
0.27 |
| Biomarker |
0 |
0.19 |
| Brain |
0 |
0.19 |
| Central Nervous System |
0 |
0.19 |
| Clinical Research |
0 |
0.19 |
| Drug Development |
0 |
0.19 |
| Immunology |
0 |
0.19 |
| Monoclonal Antibody |
0 |
0.19 |
| Multiple Sclerosis Treatment |
0 |
0.19 |
| Neuropathy |
0 |
0.19 |
| Receptors |
0 |
0.19 |
| Retinoids |
0 |
0.19 |
| Biologic Therapy |
0 |
0.13 |
| Care and Maintenance of Vision |
0 |
0.13 |
| Stem Cell Research and Therapy |
0 |
0.13 |